Literature DB >> 35783502

Plasticity in structure and assembly of SARS-CoV-2 nucleocapsid protein.

Huaying Zhao1, Ai Nguyen1, Di Wu2, Yan Li3, Sergio A Hassan4, Jiji Chen5, Hari Shroff5, Grzegorz Piszczek2, Peter Schuck1.   

Abstract

Worldwide SARS-CoV-2 sequencing efforts track emerging mutations in its spike protein, as well as characteristic mutations in other viral proteins. Besides their epidemiological importance, the observed SARS-CoV-2 sequences present an ensemble of viable protein variants, and thereby a source of information on viral protein structure and function. Charting the mutational landscape of the nucleocapsid (N) protein that facilitates viral assembly, we observe variability exceeding that of the spike protein, with more than 86% of residues that can be substituted, on average by three to four different amino acids. However, mutations exhibit an uneven distribution that tracks known structural features but also reveals highly protected stretches of unknown function. One of these conserved regions is in the central disordered linker proximal to the N-G215C mutation that has become dominant in the Delta variant, outcompeting G215 variants without further spike or N-protein substitutions. Structural models suggest that the G215C mutation stabilizes conserved transient helices in the disordered linker serving as protein-protein interaction interfaces. Comparing Delta variant N-protein to its ancestral version in biophysical experiments, we find a significantly more compact and less disordered structure. N-G215C exhibits substantially stronger self-association, shifting the unliganded protein from a dimeric to a tetrameric oligomeric state, which leads to enhanced coassembly with nucleic acids. This suggests that the sequence variability of N-protein is mirrored by high plasticity of N-protein biophysical properties, which we hypothesize can be exploited by SARS-CoV-2 to achieve greater efficiency of viral assembly, and thereby enhanced infectivity. Published by Oxford University Press on behalf of the National Academy of Sciences 2021.

Entities:  

Keywords:  SARS-CoV-2; mutational landscape; protein plasticity; quasispecies; viral assembly

Year:  2022        PMID: 35783502      PMCID: PMC9235412          DOI: 10.1093/pnasnexus/pgac049

Source DB:  PubMed          Journal:  PNAS Nexus        ISSN: 2752-6542


  73 in total

1.  COBALT: constraint-based alignment tool for multiple protein sequences.

Authors:  Jason S Papadopoulos; Richa Agarwala
Journal:  Bioinformatics       Date:  2007-03-01       Impact factor: 6.937

2.  A biophysical protein folding model accounts for most mutational fitness effects in viruses.

Authors:  C Scott Wylie; Eugene I Shakhnovich
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-24       Impact factor: 11.205

Review 3.  SARS-CoV-2 Neutralizing Antibodies for COVID-19 Prevention and Treatment.

Authors:  Dapeng Li; Gregory D Sempowski; Kevin O Saunders; Priyamvada Acharya; Barton F Haynes
Journal:  Annu Rev Med       Date:  2021-08-24       Impact factor: 13.739

4.  Proteome-wide signatures of function in highly diverged intrinsically disordered regions.

Authors:  Taraneh Zarin; Bob Strome; Alex N Nguyen Ba; Simon Alberti; Julie D Forman-Kay; Alan M Moses
Journal:  Elife       Date:  2019-07-02       Impact factor: 8.140

Review 5.  What coronavirus 3C-like protease tells us: From structure, substrate selectivity, to inhibitor design.

Authors:  Muya Xiong; Haixia Su; Wenfeng Zhao; Hang Xie; Qiang Shao; Yechun Xu
Journal:  Med Res Rev       Date:  2021-01-18       Impact factor: 12.388

6.  The SARS-CoV-2 nucleocapsid protein is dynamic, disordered, and phase separates with RNA.

Authors:  Jasmine Cubuk; Jhullian J Alston; J Jeremías Incicco; Sukrit Singh; Melissa D Stuchell-Brereton; Michael D Ward; Maxwell I Zimmerman; Neha Vithani; Daniel Griffith; Jason A Wagoner; Gregory R Bowman; Kathleen B Hall; Andrea Soranno; Alex S Holehouse
Journal:  Nat Commun       Date:  2021-03-29       Impact factor: 14.919

7.  Viral infection and transmission in a large, well-traced outbreak caused by the SARS-CoV-2 Delta variant.

Authors:  Baisheng Li; Aiping Deng; Kuibiao Li; Yao Hu; Zhencui Li; Yaling Shi; Qianling Xiong; Zhe Liu; Qianfang Guo; Lirong Zou; Huan Zhang; Meng Zhang; Fangzhu Ouyang; Juan Su; Wenzhe Su; Jing Xu; Huifang Lin; Jing Sun; Jinju Peng; Huiming Jiang; Pingping Zhou; Ting Hu; Min Luo; Yingtao Zhang; Huanying Zheng; Jianpeng Xiao; Tao Liu; Mingkai Tan; Rongfei Che; Hanri Zeng; Zhonghua Zheng; Yushi Huang; Jianxiang Yu; Lina Yi; Jie Wu; Jingdiao Chen; Haojie Zhong; Xiaoling Deng; Min Kang; Oliver G Pybus; Matthew Hall; Katrina A Lythgoe; Yan Li; Jun Yuan; Jianfeng He; Jing Lu
Journal:  Nat Commun       Date:  2022-01-24       Impact factor: 14.919

8.  Viral quasispecies.

Authors:  Esteban Domingo; Celia Perales
Journal:  PLoS Genet       Date:  2019-10-17       Impact factor: 5.917

9.  Nucleocapsid protein of SARS-CoV-2 phase separates into RNA-rich polymerase-containing condensates.

Authors:  Adriana Savastano; Alain Ibáñez de Opakua; Marija Rankovic; Markus Zweckstetter
Journal:  Nat Commun       Date:  2020-11-27       Impact factor: 14.919

10.  Architecture and self-assembly of the SARS-CoV-2 nucleocapsid protein.

Authors:  Qiaozhen Ye; Alan M V West; Steve Silletti; Kevin D Corbett
Journal:  Protein Sci       Date:  2020-08-06       Impact factor: 6.993

View more
  1 in total

Review 1.  As the virus evolves, so too must we: a drug developer's perspective : We need a new paradigm in searching for next-generation countermeasures.

Authors:  Fang Flora Fang
Journal:  Virol J       Date:  2022-10-10       Impact factor: 5.913

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.